drug discovery

June 2, 2021

Gene Linked to Bone Cancer in Children

In The News

Read Article

January 12, 2021

What DeepMind’s leap means for structure-based drug developers

In The News

Read Article

November 5, 2020

Q&A: Atomwise’s journey from discoverer to developer

In The News

Read Article

September 29, 2020

A short guide for medical professionals in the era of artificial intelligence

In The News

[Nature] Artificial intelligence (A.I.) is expected to significantly influence the practice of medicine and the delivery of healthcare in the near future. While there are only a handful of practical examples for its medical use with enough evidence, hype and attention around the topic are significant. There are so many papers, conference talks, misleading news […]

Read Article

September 24, 2020

Biopharm America: Bayer investing advances by Leaps and no boundaries

In The News

[BioWorld] Deals by Bayer AG’s “impact investment unit” called Leaps that build upon each other let the Leverkusen, Germany-based firm “basically renew [the company’s] technology platform” by tapping fresh sources, said Leaps head Jurgen Eckhardt. And the unit is casting nets widely.

Read Article

September 11, 2020

GC, Atomwise to develop new hemophilia treatment

In The News

[Korea Biomedical Review] GC said that it has partnered with Atomwise, a U.S. artificial intelligence-based drug development firm, to discover a new treatment candidate for hemophilia.

Read Article